Most have involved immunologic aspects of the tumor microenvironment such as the expression of PD‐L1 4, 5, the presence of tumor‐infiltrating T cells 6, a high mutational load 7, 8, and various specific molecular signatures, including loss of phosphatase and tensin homolog (PTEN) 9. The gene discussed is PTEN; the disease is neoplasm.